Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Neurosci Lett

Retrieve available abstracts of 33 articles:
HTML format

Single Articles

    August 2023
  1. LIU Y, Huang H, Qin X, Zheng F, et al
    Altered functional connectivity in anterior cingulate cortex subregions in treatment-resistant schizophrenia patients.
    Neurosci Lett. 2023;814:137445.
    PubMed     Abstract available

  2. FARKHAKFAR A, Hassanpour S, Zendehdel M
    Resveratrol plays neuroprotective role on ketamine-induced schizophrenia-like behaviors and oxidative damage in mice.
    Neurosci Lett. 2023;813:137436.
    PubMed     Abstract available

    July 2023
  3. LU C, Li S, Kang L, Li Q, et al
    Aripiprazole combined with nerve growth factor improves cognitive function in mice with schizophrenia model.
    Neurosci Lett. 2023 Jul 24:137410. doi: 10.1016/j.neulet.2023.137410.
    PubMed     Abstract available

    April 2023
  4. SINGH J, Singh S, Gupta S, Chavan BS, et al
    Cognitive Remediation and Schizophrenia: Effects on Brain Complexity.
    Neurosci Lett. 2023 Apr 24:137268. doi: 10.1016/j.neulet.2023.137268.
    PubMed     Abstract available

  5. ZAHRA RAMI F, Kim WS, Shen J, Tsogt U, et al
    Differential effects of parental socioeconomic status on cortical thickness in patients with schizophrenia spectrum disorders and healthy controls.
    Neurosci Lett. 2023 Apr 7:137239. doi: 10.1016/j.neulet.2023.137239.
    PubMed     Abstract available

    December 2022
    The immune-stress/endocrine-redox-metabolic nature of psychosis' etiopathology; focus on the intersystemic pathways interactions.
    Neurosci Lett. 2022;794:137011.
    PubMed     Abstract available

    November 2022
  7. GORNEROVA N, Brunovsky M, Klirova M, Novak T, et al
    The effect of Low-Frequency rTMS on Auditory Hallucinations, EEG Source Localization and Functional Connectivity in Schizophrenia.
    Neurosci Lett. 2022 Nov 22:136977. doi: 10.1016/j.neulet.2022.136977.
    PubMed     Abstract available

    October 2022
  8. PAN B, Xu L, Weng J, Wang Y, et al
    Effects of icariin on alleviating schizophrenia-like symptoms by regulating the miR-144-3p/ATP1B2/mTOR signalling pathway.
    Neurosci Lett. 2022 Oct 16:136918. doi: 10.1016/j.neulet.2022.136918.
    PubMed     Abstract available

    August 2022
  9. LIN C, Gou M, Pan S, Tong J, et al
    Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: moderated by brain cortical thickness.
    Neurosci Lett. 2022 Aug 6:136826. doi: 10.1016/j.neulet.2022.136826.
    PubMed     Abstract available

    July 2022
  10. LIU C, Xu X, Liu X, Zhang T, et al
    DRD3 Ser9Gly polymorphism and treatment response to antipsychotics in schizophrenia: A meta-analysis.
    Neurosci Lett. 2022;786:136788.
    PubMed     Abstract available

    June 2022
  11. RIEL H, MacPhee C, Rudolph ED, Tibbo PG, et al
    MMN and P3a elicited by a novelty paradigm in healthy controls: An investigation of sex differences.
    Neurosci Lett. 2022;781:136654.
    PubMed     Abstract available

    May 2022
  12. REN J, Chen Y, Fang X, Wang D, et al
    Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine.
    Neurosci Lett. 2022 May 23:136695. doi: 10.1016/j.neulet.2022.136695.
    PubMed     Abstract available

  13. ZHANG M, Hong X, Yang F, Fan H, et al
    Structural brain imaging abnormalities correlate with positive symptom in schizophrenia.
    Neurosci Lett. 2022 May 17:136683. doi: 10.1016/j.neulet.2022.136683.
    PubMed     Abstract available

    March 2022
  14. LI N, Huang J, Zhang P, Tong J, et al
    Dysfunctional monocytic toll-like receptor 4 signaling pathway and cognitive deficits in chronic schizophrenia patients with tardive dyskinesia.
    Neurosci Lett. 2022 Mar 22:136581. doi: 10.1016/j.neulet.2022.136581.
    PubMed     Abstract available

    February 2022
  15. CHENG P, Zhang R, Shan S, Yuan B, et al
    Novel IL1RAP mutation associated with schizophrenia interferes with neuronal growth and related NF-kappaB signal pathways.
    Neurosci Lett. 2022 Feb 15:136533. doi: 10.1016/j.neulet.2022.136533.
    PubMed     Abstract available

    December 2021
  16. SMUCNY J, Carter CS, Maddock RJ
    Magnetic resonance spectroscopic evidence of increased choline in the dorsolateral prefrontal and visual cortices in recent onset schizophrenia.
    Neurosci Lett. 2021;770:136410.
    PubMed     Abstract available

  17. YAN P, Gao B, Wang S, Wang S, et al
    Association of 5-HTR2A T102C and A-1438G polymorphisms with clinical response to atypical antipsychotic treatment in schizophrenia: A meta-analysis.
    Neurosci Lett. 2021;770:136395.
    PubMed     Abstract available

  18. LIU L, Hu Y, Lu Y, Hu L, et al
    Sex-dependent DNA hypermethylation of SLC6A4 in patients with schizophrenia.
    Neurosci Lett. 2021;769:136394.
    PubMed     Abstract available

    November 2021
  19. AZIMI SANAVI M, Ghazvini H, Ghalehnoei H, Zargari M, et al
    Effects of Clozapine and Risperidone Antipsychotic Drugs on the Expression of CACNA1C and Behavioral Changes in Rat 'Ketamine Model of Schizophrenia.
    Neurosci Lett. 2021 Nov 18:136354. doi: 10.1016/j.neulet.2021.136354.
    PubMed     Abstract available

    October 2021
  20. JUNG HY, Jung S, Bang M, Choi TK, et al
    White matter correlates of impulsivity in frontal lobe and their associations with treatment response in first-episode schizophrenia.
    Neurosci Lett. 2021 Oct 28:136309. doi: 10.1016/j.neulet.2021.136309.
    PubMed     Abstract available

    September 2021
  21. MOGHADDAM AH, Maboudi K, Bavaghar B, Sangdehi SRM, et al
    Neuroprotective effects of curcumin-loaded nanophytosome on ketamine-induced schizophrenia-like behaviors and oxidative damage in male mice.
    Neurosci Lett. 2021;765:136249.
    PubMed     Abstract available

  22. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    PubMed     Abstract available

    July 2021
  23. MAREDIA M, Hamilton J, Thanos PK
    A high-fat diet, but not haloperidol or olanzapine administration, increases activated microglial expression in the rat brain.
    Neurosci Lett. 2021;757:135976.
    PubMed     Abstract available

  24. VALES K, Holubova K
    Minireview: Animal model of schizophrenia from the perspective of behavioral pharmacology: effect of treatment on cognitive functions.
    Neurosci Lett. 2021 Jul 2:136098. doi: 10.1016/j.neulet.2021.136098.
    PubMed     Abstract available

    June 2021
  25. RAMPINO A, Annese T, Torretta S, Tamma R, et al
    Involvement of Vascular Endothelial Growth Factor in schizophrenia.
    Neurosci Lett. 2021 Jun 30:136093. doi: 10.1016/j.neulet.2021.136093.
    PubMed     Abstract available

  26. ZHANG Q, He H, Cao B, Gao R, et al
    Analysis of cognitive impairment in schizophrenia based on machine learning: Interaction between psychological stress and immune system.
    Neurosci Lett. 2021;760:136084.
    PubMed     Abstract available

    The endocannabinoid system as a therapeutic target for schizophrenia: failures and potentials.
    Neurosci Lett. 2021 Jun 16:136064. doi: 10.1016/j.neulet.2021.136064.
    PubMed     Abstract available

  28. PATRIK S, Filip S
    Brain ventricular volume changes in schizophrenia. A narrative review.
    Neurosci Lett. 2021 Jun 16:136065. doi: 10.1016/j.neulet.2021.136065.
    PubMed     Abstract available

  29. ANDROVICOVA R, Pfaus JG, Ovsepian SV
    Estrogen Pendulum in Schizophrenia and Alzheimer's Disease: Review of Therapeutic Benefits and Outstanding Questions.
    Neurosci Lett. 2021 Jun 8:136038. doi: 10.1016/j.neulet.2021.136038.
    PubMed     Abstract available

  30. KOLAR D, Kleteckova L, Brozka H, Vales K, et al
    Mini-Review: Brain Energy Metabolism and its Role in Animal Models of Depression, Bipolar Disorder, Schizophrenia and Autism.
    Neurosci Lett. 2021 Jun 4:136003. doi: 10.1016/j.neulet.2021.136003.
    PubMed     Abstract available

    April 2021
  31. MEIRON O, David J, Yaniv A
    Left prefrontal transcranial direct-current stimulation reduces symptom-severity and acutely enhances working memory in schizophrenia.
    Neurosci Lett. 2021;755:135912.
    PubMed     Abstract available

    January 2021
  32. CAI Y, Xing L, Yang T, Chai R, et al
    The neurodevelopmental role of dopaminergic signaling in neurological disorders.
    Neurosci Lett. 2021;741:135540.
    PubMed     Abstract available

    February 2020
  33. CALABRO M, Porcelli S, Crisafulli C, Albani D, et al
    Genetic variants associated with psychotic symptoms across psychiatric disorders.
    Neurosci Lett. 2020;720:134754.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.